Baker Bros. Advisors’s Axsome Therapeutics AXSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-610,970
Closed -$25.3M 118
2022
Q1
$25.3M Hold
610,970
0.15% 46
2021
Q4
$23.1M Buy
610,970
+71,913
+13% +$2.65M 0.11% 56
2021
Q3
$17.8M Hold
539,057
0.08% 66
2021
Q2
$36.4M Sell
539,057
-89,357
-14% -$5.36M 0.16% 47
2021
Q1
$35.6M Sell
628,414
-150,420
-19% -$10.6M 0.15% 52
2020
Q4
$63.5M Sell
778,834
-180,923
-19% -$13.5M 0.24% 28
2020
Q3
$68.4M Sell
959,757
-50,000
-5% -$3.9M 0.27% 23
2020
Q2
$83.1M Buy
1,009,757
+120,000
+13% +$9.24M 0.37% 23
2020
Q1
$52.3M Buy
889,757
+60,000
+7% +$4.89M 0.32% 26
2019
Q4
$85.8M Buy
829,757
+57,471
+7% +$2.32M 0.46% 22
2019
Q3
$15.6M Hold
772,286
0.11% 42
2019
Q2
$19.9M Sell
772,286
-427,714
-36% -$8.57M 0.14% 39
2019
Q1
$17.1M Buy
+1,200,000
New +$11.1M 0.11% 39

Other funds holding AXSM